Medical device recalls Moderate risk

Medtest Holdings, Inc. recalls Liquid stable 2 part Homocysteine Reagent, for in vitro quantitative determination of total homocysteine in human serum…

Recall date
April 3, 2015
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2063-2016
FDA classification
Class II
Brand / firm
Medtest Holdings, Inc.
Sold / distributed
MI, MN, NJ, IL, NY. US Only.

Why it was recalled

Deterioration in performance of the Liquid Stable (LS) 2-Part HOMOCYSTEINE REAGENT resulting in under recovery. The manufacturer has indicated that the HOMOCYSTEINE REAGENT lot listed above shows deterioration in assay performance manifesting itself by under recovery of Homocysteine in Controls and Patient Samples. The cause of this deterioration has been attributed to a loss of reductant activity in Reagent 1. Testing performed indicated that the affected lot is at the limit of acceptable clinical performance. This observation was consistent across the reportable range of the assay. For this reason, do not continue to use affected reagent lot. Test data generated to date will be acceptable where validity control specifiCations have been met.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Liquid stable 2 part Homocysteine Reagent, for in vitro quantitative determination of total homocysteine in human serum and plasma - H7575-57 kit includes one Rl and one R2 bottle and one bottle of calibrator level 1 and one bottle of calibrator level 2.

Get recall alerts

Free email alert whenever Medtest Holdings, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Medtest Holdings, Inc.